{'fraction_non_alphanumeric': 0.035505430242272346, 'fraction_numerical': 0.01921470342522974, 'mean_word_length': 4.322222222222222, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Abstract TP259: Neuroprotective Effects Of Ripk2 Deficiency In Experimental Ischemic Stroke


 Background:
 Receptor-interacting serine-threonine protein kinase 2 (Ripk2) is involved in the signaling pathways of members of the NOD family of cytosolic pattern recognition receptors. Ripk2 has been implicated in the caspase-1 pathway of hypoxia and ischemia-induced neuronal cell death, as well as the pathology of neuroinflammatory diseases like multiple sclerosis. Ischemic stroke is characterized by brain injury resulting from initial hypoxia/ischemia-induced cell death and secondary neuroinflammation.
 
 
 Hypothesis:
 Since Ripk2 is implicated in both pathways, we hypothesized that the genetic deletion of Ripk2 will improve outcomes for animals after experimental stroke.
 
 
 Methods:
 We utilized
 Ripk2
 knockout (
 Ripk2
 -/-
 ) mice (3-4 months old) and subjected them to 45min of transient middle cerebral artery occlusion (tMCAO) along with wild-type (WT) control littermates. Infarct size was measured at 24h by TTC staining. RNA was isolated from the ipsilateral and contralateral cortices for RT-qPCR. Weight grip test, vertical grid test, and open field behavioral tests were conducted before and up to 21 days after tMCAO with novel object recognition and Y-maze tests occurring at day 28.
 
 
 Results:
 After 24h,
 Ripk2
 -/-
 mice had significantly smaller infarct sizes than wild-type (WT) mice.
 Ripk2
 -/-
 mice also had much lower expression of proinflammatory cytokines (
 Tnfα, Il1β,
 and
 Il6
 ) and chemokines (
 Ccl2
 and
 Cxcl1
 ) in the ipsilateral cortex relative to WT, implicating a diminished proinflammatory response to ischemia/reperfusion injury in
 Ripk2
 -/-
 animals.
 Ripk2
 -/-
 mice displayed significantly better neurological deficit scores compared to WT at 24h, 48h, 7d, 14d, and 21d post-tMCAO.
 Ripk2
 -/-
 mice also performed much better than WT at acute time points in a battery of behavioral tests, such as the weight grip test, vertical grid test, and open field test. Neurological assessment via novel object recognition and Y-maze tests showed no difference between genotypes at 28d.
 
 
 Conclusions:
 Our findings support the hypothesis that Ripk2 plays a detrimental role in the pathology of ischemic stroke. Understanding Ripk2’s role in stroke pathology may reveal a novel therapeutic target for the treatment of ischemic stroke.
